Transplant Group Control Group P-value
Number of patients, (n) 14 56 -
Number of procedures, (n) 15 62 -
Repeat ablation, n (%) 1(7.1) 6(10.7) 1.000
Procedure time, minutes 135.7±41.3 129.8±41.1 0.529
Fluoroscopic time, minutes 7.9±5.7 6.3±4.8 0.568
Procedure strategy
CPVI, n (%) 15(100.0) 61(98.4) 0.621
CTI, n (%) 9(60.0) 25(40.3) 0.168
Other linear ablation, n (%) 6(40.0) 19(30.6) 0.545
SVCI, n (%) 1(6.7) 6(9.7) 1.000
Cardioversion, n (%) 5(33.3) 17(27.4) 0.752
Periprocedural complications
Stroke/TIA, n (%) 0(0.0) 0(0.0) -
Cardiac tamponade/effusion, n (%)
0(0.0)
0(0.0)
-
Myocardial infarction, n (%) 0(0.0) 0(0.0) -
Major bleeding, n (%) 0(0.0) 0(0.0) -
Pseudoaneurysm, n (%) 0(0.0) 1(1.6) 1.000
Groin hematoma, n (%) 1(6.7) 1(1.6) 0.354